The sequence of events -- The Tennessee anti-evolution act -- The first book of Moses, called Genesis -- Darwin: the theory of evolution : From The Origin of Species ; From The Descent of Man -- ...

Alto Neuroscience Inc. (NYSE:ANRO) is one of the best IPO stocks to buy according to Wall Street analysts. On June 26, Alto Neuroscience announced positive pharmacodynamic results from an exploratory ...

Scientists at UC Davis and UC San Francisco have conducted a clinical trial on cats with squamous cell carcinoma, revealing promising results that could extend to human treatments. Scientists at UC ...

This year marks the 100-year anniversary of the infamous trial of The State of Tennessee v. John Thomas Scopes, better known as the Scopes Monkey Trial. Much of what happened during this circus of a ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best IPO stocks to buy according to Wall Street analysts. Earlier on July 8, Upstream Bio announced that the first patient had been dosed in a Phase 2 ...

Sept 2 (Reuters) - Ionis Pharmaceuticals' (IONS.O), opens new tab shares surged on Tuesday after its drug significantly lowered the levels of a type of blood fat and the risk of a pancreatic disease ...

Drug developers with products targeting a liver condition called metabolic dysfunction-associated steatohepatitis (MASH) traded higher on Wednesday after the U.S. FDA said it has accepted an ...

(Reuters) -Ionis Pharmaceuticals' shares surged on Tuesday after its drug significantly lowered the levels of a type of blood fat and the risk of a pancreatic disease in two late-stage studies, ...

Sept 2 (Reuters) - Merck's (MRK.N), opens new tab oral drug met the main goal of reducing bad cholesterol in a late-stage trial, it said on Tuesday, marking a second win for the drug since June. The ...

This year a clinical trial will test a drug combination designed to bring lasting relief for people with panic disorder – a condition that can upend daily life and be notoriously difficult to treat.

DENVER (KDVR) — An alleged drug dealer has avoided going to trial by pleading guilty to multiple charges connected to a 2023 overdose death and distribution of illegal substances, according to Boulder ...

Alpha1H demonstrated significant tumor reduction and immune activation in non-muscle invasive bladder cancer, with an 80% response rate and 59% average tumor shrinkage in high-dose groups. The drug ...